Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex, Inc.

40.19
+0.84002.13%
Post-market: 40.310.1200+0.30%16:45 EDT
Volume:777.37K
Turnover:31.07M
Market Cap:6.36B
PE:-118.38
High:40.56
Open:39.20
Low:39.01
Close:39.35
Loading ...

Vertex Pharmaceuticals Ends VX-264 Study in Diabetes After Failing to Meet Efficacy Endpoint

MT Newswires Live
·
31 Mar

Vertex Pharmaceuticals’ Journavx: Strong Demand and Positive Outlook Drive Buy Rating

TIPRANKS
·
31 Mar

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

ACCESS Newswire
·
31 Mar

Vertex Minerals Starts Trading on US OTCQB Market; Shares Fall 4%

MT Newswires Live
·
31 Mar

Vertex Pharmaceuticals (NasdaqGS:VRTX) Advances Diabetes Portfolio Despite 2% Decline in Share Price

Simply Wall St.
·
30 Mar

Vertex Pharmaceuticals: Strategic Advancements and Promising Market Potential Drive Buy Rating

TIPRANKS
·
29 Mar

Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March?

Insider Monkey
·
29 Mar

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
29 Mar

Vertex Pharmaceuticals pursuing research-stage T1Dd programs

TIPRANKS
·
29 Mar

IHI to Sell Construction Materials Business to Vertex to Focus on Growth Areas

MT Newswires Live
·
28 Mar

Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors

Zacks
·
28 Mar

Vertex, Inc. (NASDAQ:VERX) Has Found A Path To Profitability

Simply Wall St.
·
28 Mar

Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead. -- Barrons.com

Dow Jones
·
27 Mar

IHI Corporation Transfers Shares of Construction Subsidiary to Vertex

TIPRANKS
·
27 Mar

Vertex Commerce Study: Returnuary’s Growing Complexity Forces Retailers to Keep Pace

GlobeNewswire
·
26 Mar

Explorers Podcast: Vertex ready to claim its gold Reward

Stockheads
·
26 Mar

Analysts Have Conflicting Sentiments on These Healthcare Companies: Nevro Corp (NVRO), Globus Medical (GMED) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
25 Mar

Vertex Pharmaceuticals Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
25 Mar

JPMorgan Adjusts Price Target on Vertex Pharmaceuticals to $512 From $500, Keeps Overweight Rating

MT Newswires Live
·
24 Mar

Press Release: Vertex Resource Group Ltd. Reports Fourth Quarter and Year End 2024 Results

Dow Jones
·
24 Mar